NASDAQ:RSSS

Research Solutions (RSSS) Stock Price, News & Analysis

$3.00
-0.12 (-3.85%)
(As of 04/25/2024 ET)
Today's Range
$2.93
$3.07
50-Day Range
$2.83
$3.43
52-Week Range
$1.80
$3.50
Volume
16,584 shs
Average Volume
55,105 shs
Market Capitalization
$97.86 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.78

Research Solutions MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
59.4% Upside
$4.78 Price Target
Short Interest
Healthy
0.04% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.13mentions of Research Solutions in the last 14 days
Based on 28 Articles This Week
Insider Trading
Selling Shares
$123,295 Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.74 out of 5 stars

Industrial Products Sector

132nd out of 168 stocks

Business Services, Not Elsewhere Classified Industry

66th out of 86 stocks

RSSS stock logo

About Research Solutions Stock (NASDAQ:RSSS)

Research Solutions, Inc., through its subsidiaries, provides cloud-based software-as-a-service research platform. The company is also involved in the transactional sale of published scientific, technical, and medical (STM) content managed, sourced, and delivered through the Transactions platform. Its solutions enable life science and other research intensive organizations to accelerate their research and development activities with access and management STM articles used throughout the intellectual property development lifecycle. The company was formerly known as Derycz Scientific, Inc. and changed its name to Research Solutions, Inc. in March 2013. Research Solutions, Inc. was incorporated in 2006 and is based in Henderson, Nevada.

RSSS Stock Price History

RSSS Stock News Headlines

Better than Bitcoin? The Biotech Stock with 46,751% Potential
4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.
Better than Bitcoin? The Biotech Stock with 46,751% Potential
4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.
See More Headlines
Receive RSSS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Research Solutions and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
9/13/2023
Today
4/25/2024
Next Earnings (Estimated)
5/09/2024
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Industry
Business services, not elsewhere classified
Sub-Industry
N/A
Current Symbol
NASDAQ:RSSS
Employees
145
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$4.78
High Stock Price Target
$5.00
Low Stock Price Target
$4.35
Potential Upside/Downside
+53.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$570,000.00
Pretax Margin
-0.96%

Debt

Sales & Book Value

Annual Sales
$37.70 million
Cash Flow
$0.02 per share
Book Value
$0.25 per share

Miscellaneous

Free Float
23,985,000
Market Cap
$101.77 million
Optionable
Not Optionable
Beta
0.60
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Mr. Roy W. Olivier (Age 65)
    President, CEO & Director
    Comp: $523.33k
  • Mr. William A. Nurthen (Age 51)
    CFO & Secretary
    Comp: $405.06k
  • Mr. Scott Ahlberg (Age 61)
    Chief Operating Officer
    Comp: $357.69k
  • Mr. Frank Buckley
    Account Manager
  • Mr. Rick Salloum
    Chief Technology Officer
  • Mr. Tedd Adams
    Director of Sales
  • Mr. Alan Louis Urban CPA (Age 56)
    Executive Officer
    Comp: $390.12k
  • Mr. Shane Alan Hunt (Age 47)
    Chief Revenue Officer
  • Mr. Michiel van der Heijden (Age 53)
    Chief Product Officer
  • Mr. Tony Landolt
    Head of Academic Business Development

RSSS Stock Analysis - Frequently Asked Questions

Should I buy or sell Research Solutions stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Research Solutions in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" RSSS shares.
View RSSS analyst ratings
or view top-rated stocks.

What is Research Solutions' stock price target for 2024?

3 equities research analysts have issued twelve-month price objectives for Research Solutions' shares. Their RSSS share price targets range from $4.35 to $5.00. On average, they expect the company's stock price to reach $4.78 in the next twelve months. This suggests a possible upside of 59.4% from the stock's current price.
View analysts price targets for RSSS
or view top-rated stocks among Wall Street analysts.

How have RSSS shares performed in 2024?

Research Solutions' stock was trading at $2.60 at the start of the year. Since then, RSSS shares have increased by 15.4% and is now trading at $3.00.
View the best growth stocks for 2024 here
.

Are investors shorting Research Solutions?

Research Solutions saw a decline in short interest in April. As of April 15th, there was short interest totaling 10,600 shares, a decline of 74.2% from the March 31st total of 41,100 shares. Based on an average daily trading volume, of 61,000 shares, the days-to-cover ratio is presently 0.2 days. Currently, 0.0% of the company's stock are sold short.
View Research Solutions' Short Interest
.

When is Research Solutions' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our RSSS earnings forecast
.

How were Research Solutions' earnings last quarter?

Research Solutions, Inc. (NASDAQ:RSSS) released its earnings results on Wednesday, September, 13th. The company reported $0.01 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.01) by $0.02. The firm earned $9.96 million during the quarter, compared to analyst estimates of $9.70 million. Research Solutions had a negative net margin of 1.05% and a negative trailing twelve-month return on equity of 4.96%. During the same quarter in the prior year, the business earned ($0.02) earnings per share.

Who are Research Solutions' major shareholders?

Research Solutions' stock is owned by a variety of retail and institutional investors. Top institutional investors include Hodges Capital Management Inc. (0.97%). Insiders that own company stock include Alan Louis Urban, Bristol Investment Fund Ltd, Eugene Vlad Robin, Kurt L Darrow, Marc Nissan, Peter Derycz and Roy W Olivier.
View institutional ownership trends
.

How do I buy shares of Research Solutions?

Shares of RSSS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:RSSS) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners